HPV Self-Test Intervention in Ohio Appalachia

Completed · Not applicable

Conditions studied: Cervical Carcinoma, Human Papillomavirus Infection

In brief

This study will pilot test a culturally appropriate human papillomavirus (HPV) self-test intervention among women from Ohio Appalachia in order to determine the feasibility of HPV self-testing as a potential cervical cancer screening strategy. The intervention group will receive culturally appropriate materials and the control group will receive standard materials with their HPV self-test device.

Key facts

Study ID

NCT02460237

Run by

Ohio State University Comprehensive Cancer Center

People needed

103

Starts

2015-11-01

Expected to finish

2017-03-15

Last updated by the study team

2018-02-08

Who can join

Age: 30 and older, up to 65. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Ages 30-65
• No Pap test in the last 3 years
• Resident of an Ohio Appalachia county
• Not currently pregnant or was not pregnant in the last 3 months
• No history of invasive cervical cancer
• No history of hysterectomy; women will not be eligible for the pilot randomized controlled trial (RCT) if they participated in the focus groups that helped develop this study (focus groups were institutional review board [IRB] approved as Protocol 2014C0086) or the preliminary device test; we will also require women to read and understand English and have the ability to provide informed consent, which will be inferred upon completion and return of the study eligibility, consent, and Health Insurance Portability and Accountability Act (HIPAA) forms

Where it is running

• Ohio State University Comprehensive Cancer Center — Columbus, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.